FDA Inspection
KP Pharmaceutical TechnologyKP Pharmaceutical Technology – FDA Inspection, Nov 9, 2017
Record Details
This FDA Inspection record concerns KP Pharmaceutical Technology, with an inspection on November 9, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ed200eb9-bfc3-4a44-bc83-0809093ee866
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031466
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of KP Pharmaceutical Technology
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Detroit District Office | |
| March 21, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2023 | OAI | Drug Quality Assurance | |
| May 21, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for KP Pharmaceutical Technology
- FDA Inspection 1307874 - 2026-02-13
- FDA Inspection 1234088 - 2024-03-21
- FDA Inspection 1196557 - 2023-02-03
- FDA Inspection 940349 - 2015-05-21
- FDA Inspection 814448 - 2012-12-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.